Genetic and hormonal influence on SARS-CoV-2-infection susceptibility: Re: The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality

por Montopoli, M., Zumerle, S., Rugge, M., Alimonti, A.
Publicado 2020

Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M....

por Zumerle, S., Montopoli, M., Rugge, M., Alimonti, A.
Publicado 2020

Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy

por Montopoli, M., Zorzi, M., Cocetta, V., Prayer-Galetti, T., Guzzinati, S., Bovo, E., Rugge, M., Calcinotto, A.
Publicado 2021

Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Li...

por Berretta, M., Morra, A., Taibi, R., Monari, F., Maurea, N., Ippolito, M., Tirelli, U., Fiorica, F., Montella, L., Facchini, G., Quagliariello, V., Montopoli, M.
Publicado 2022

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)

por Montopoli, M., Zumerle, S., Vettor, R., Rugge, M., Zorzi, M., Catapano, C.V., Carbone, G.M., Cavalli, A., Pagano, F., Ragazzi, E., Prayer-Galetti, T., Alimonti, A.
Publicado 2020